IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study

被引:41
作者
Shen, Jiayun [1 ]
Shang, Qing [1 ]
Wong, Chun-Kwok [2 ]
Li, Edmund K. [1 ]
Wang, Shang [1 ]
Li, Rui-Jie [1 ]
Lee, Ka-Lai [3 ]
Leung, Ying-Ying [4 ]
Ying, King-Yee [5 ]
Yim, Cheuk-Wan [6 ]
Kun, Emily W. [7 ]
Leung, Moon-Ho [8 ]
Li, Martin [1 ]
Li, Tena K. [1 ]
Zhu, Tracy Y. [1 ]
Yu, Shui-Lian [1 ]
Kuan, Woon-Pang [1 ]
Yu, Cheuk-Man [1 ]
Tam, Lai-Shan [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China
[3] Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[4] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore
[5] Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[6] Tseung Kwan O Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[7] Taipo Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China
[8] Queen Elizabeth Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
Early rheumatoid arthritis; IL-33; Soluble ST2; Disease remission; Atherosclerosis; Carotid plaque; CARDIOVASCULAR MORTALITY; RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; DISEASE; PROTEIN; RISK; RECEPTOR; ATHEROSCLEROSIS; EXPRESSION; CYTOKINE;
D O I
10.1016/j.semarthrit.2015.02.001
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objectives: To study the association between the baseline IL-33 and soluble ST2 (sST2) levels with disease remission and progression of carotid atherosclerosis in early rheumatoid arthritis (ERA) patients. Methods: A total of 98 ERA patients were enrolled. Disease activity and the presence of carotid plaque were evaluated at baseline and 12 months later. Plasma IL-33 and sST2 levels were determined using enzyme-linked immunosorbent assay kits. Results: Baseline IL-33 and sST2 levels were associated with inflammatory markers and cardiovascular (CV) risk factors. Overall, 44(45%), 18(18%), and 21(21%) patients achieved remission based on 28-joint disease activity score (DAS28), Boolean, and simplified disease activity score (SDAI) criteria at 12 months, respectively. Patients with detectable IL-33 at baseline were less likely to achieve DAS28 (P = 0.010) and SDAI remission (P = 0.021), while a lower baseline sST2 level was able to predict DAS28, Boolean, and SDAI remission (P = 0.005, 0.001, and < 0.001, respectively). Using multivariate analysis, a lower baseline sST2 level independently predict Boolean (OR = 0.789; P = 0.005) and SDAI remission (0.812; P = 0.008). Regarding carotid atherosclerosis, 9/98(9.2%) patients had plaque progression at 12 months. Baseline IL-33 was detectable in 8/9(89%) and 42/83(51%) of patients with and without plaque progression respectively (P = 0.029). Baseline detectable IL-33 was an independent predictor for plaque progression after adjusting for traditional CV risk factors (P = 0.017). Conclusions: Lower baseline 5ST2 levels independently predict disease remission and baseline detectable IL-33 independently predicts carotid plaque progression in ERA patients. This study suggests that inflammation induced by the IL-33/ST2 axis may play a significant role in the development of cardiovascular disease in RA. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:18 / 27
页数:10
相关论文
共 51 条
[1]
Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states [J].
Aletaha, D ;
Ward, MM ;
Machold, KP ;
Nell, VPK ;
Stamm, T ;
Smolen, JS .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2625-2636
[2]
Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]
[3]
ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells [J].
Aoki, Shinsuke ;
Hayakawa, Morisada ;
Ozaki, Hiromi ;
Takezako, Naoki ;
Obata, Hiroto ;
Ibaraki, Nobuhiro ;
Tsuru, Tadahiko ;
Tominaga, Shin-ichi ;
Yanagisawa, Ken .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2010, 335 (1-2) :75-81
[4]
Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies [J].
Avina-Zubieta, J. Antonio ;
Choi, Hyon K. ;
Sadatsafavi, Mohsen ;
Etminan, Mahyar ;
Esdaile, John M. ;
Lacaille, Diane .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12) :1690-1697
[5]
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma [J].
Brunner, M ;
Krenn, C ;
Roth, G ;
Moser, B ;
Dworschak, M ;
Jensen-Jarolim, E ;
Spittler, A ;
Sautner, T ;
Bonaros, N ;
Wolner, E ;
Boltz-Nitulescu, G ;
Ankersmit, HJ .
INTENSIVE CARE MEDICINE, 2004, 30 (07) :1468-1473
[6]
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo [J].
Carriere, Virginie ;
Roussel, Lucie ;
Ortega, Nathalie ;
Lacorre, Delphine-Armelle ;
Americh, Laure ;
Aguilar, Luc ;
Bouche, Gerard ;
Girard, Jean-Philippe .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) :282-287
[7]
Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production [J].
Choi, Yeon-Sook ;
Choi, Hyun-Jung ;
Min, Jeong-Ki ;
Pyun, Bo-Jeong ;
Maeng, Yong-Sun ;
Park, Hongryeol ;
Kim, Jihye ;
Kim, Young-Myeong ;
Kwon, Young-Guen .
BLOOD, 2009, 114 (14) :3117-3126
[8]
Interleukin-33 Induces Expression of Adhesion Molecules and Inflammatory Activation in Human Endothelial Cells and in Human Atherosclerotic Plaques [J].
Demyanets, Svitlana ;
Konya, Viktoria ;
Kastl, Stefan P. ;
Kaun, Christoph ;
Rauscher, Sabine ;
Niessner, Alexander ;
Pentz, Richard ;
Pfaffenberger, Stefan ;
Rychli, Kathrin ;
Lemberger, Christof E. ;
de Martin, Rainer ;
Heinemann, Akos ;
Huk, Ihor ;
Groeger, Marion ;
Maurer, Gerald ;
Huber, Kurt ;
Wojta, Johann .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (09) :2080-U440
[9]
Soluble ST2: A new and promising activity marker in ulcerative colitis [J].
Diaz-Jimenez, David ;
Nunez, Lucia E. ;
Beltran, Caroll J. ;
Candia, Enzo ;
Suazo, Cristobal ;
Alvarez-Lobos, Manuel ;
Gonzalez, Maria-Julieta ;
Hermoso, Marcela A. ;
Quera, Rodrigo .
WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (17) :2181-2190
[10]
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials [J].
Felson, David T. ;
Smolen, Josef S. ;
Wells, George ;
Zhang, Bin ;
van Tuyl, Lilian H. D. ;
Funovits, Julia ;
Aletaha, Daniel ;
Allaart, Cornelia F. ;
Bathon, Joan ;
Bombardieri, Stefano ;
Brooks, Peter ;
Brown, Andrew ;
Matucci-Cerinic, Marco ;
Choi, Hyon ;
Combe, Bernard ;
de Wit, Maarten ;
Dougados, Maxime ;
Emery, Paul ;
Furst, Daniel ;
Gomez-Reino, Juan ;
Hawker, Gillian ;
Keystone, Edward ;
Khanna, Dinesh ;
Kirwan, John ;
Kvien, Tore K. ;
Landewe, Robert ;
Listing, Joachim ;
Michaud, Kaleb ;
Martin-Mola, Emilio ;
Montie, Pamela ;
Pincus, Theodore ;
Richards, Pamela ;
Siegel, Jeffrey N. ;
Simon, Lee S. ;
Sokka, Tuulikki ;
Strand, Vibeke ;
Tugwell, Peter ;
Tyndall, Alan ;
van der Heijde, Desiree ;
Verstappen, Suzan ;
White, Barbara ;
Wolfe, Frederick ;
Zink, Angela ;
Boers, Maarten .
ARTHRITIS AND RHEUMATISM, 2011, 63 (03) :573-586